NYMC > Faculty > Faculty Profiles > By Name > Naidu, Srihari

Srihari S. Naidu, M.D., FACC, FAHA, FSCAI

SquareProfessor of Medicine

Phone: (914) 598-7651

Srihari S. Naidu, M.D., FACC, FAHA, FSCAI, is triple board-certified in internal medicine, cardiology, and interventional cardiology, and has been featured in Westchester Magazine and on the cover of Cardiovascular Business, both of which highlighted his national role in hypertrophic cardiomyopathy, the most common cause of sudden cardiac death in athletes and a common cause of heart failure.  Dr. Naidu is a pioneer in the minimally-invasive alternative to open heart surgery known as alcohol septal ablation and performs the highest volume annually of this procedure in the United States.

He began his career as an attending at New York Presbyterian – Cornell and New York University Winthrop, before joining the faculty at New York Medical College and Westchester Medical Center, where he directs both the Hypertrophic Cardiomyopathy (HCM) National Center of Excellence and the cardiac catheterization laboratories for the network.

The HCM Center at Westchester Medical Center is one of the ten busiest in the nation, treating thousands of patients with this disease.  Dr. Naidu edits the only comprehensive textbook, Hypertrophic Cardiomyopathy (Springer, Inc.), launching its third edition, and also runs an annual live proctoring course for others interested in learning the technique and bringing it back to their hospital.

Dr. Naidu is also an expert in cardiogenic shock and mechanical support devices to help the failing heart. In 2019, he chaired the writing group on a new universal definition of cardiogenic shock that has become the standard across the world, and he has been instrumental in both developing technologies for cardiogenic shock and validating the definition.

Dr. Naidu has more than 200 original manuscripts, book chapters, and review articles, and lectures widely across the United States, Europe, and Asia on his topics of expertise.  A regularly invited speaker at the American Heart Association (AHA) and the American College of Cardiology (ACC), he has chaired several national guidelines and consensus documents on behalf of both organizations. 

Dr. Naidu holds several national professional roles and is currently president of the New York Chapter of the ACC representing all cardiologists within the State and sits on the Board of Governors of the National ACC in Washington, DC.

He has also served as past trustee of the Society for Cardiovascular Angiography and Interventions (SCAI) and will take on the role of president from 2025 to 2026 leading the field of interventional cardiology. In New York State, he is a member of the Cardiac Advisory Council, appointed by Governor Kathy Hochul.  He is also active at his alma mater Brown University as trustee emeritus of the University and past president of its Medical School Board.


  • B.S., Neuroscience, Brown University
  • M.D., The Warren Alpert Medical School, Brown University
  • Residency: Internal Medicine, New York Presbyterian Hospital – Cornell Medical Center
  • Fellowships: Cardiology and Interventional Cardiology, University of Pennsylvania


  • Bali AD, Malik A, Naidu SS, et. al. "Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique." The American journal of cardiology, 212S(), (2024) S42-S52. doi: 10.1016/j.amjcard.2023.10.064
  • Hanson ID, Rusia A, Palomo A, et. al. "Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage." Journal of the American Heart Association, 13(3), (2024) e031803. doi: 10.1161/JAHA.123.031803
  • Patel J, Wang A, Naidu SS, et. al. "Aficamten-A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy." Cardiology in review, (), (2023) . doi: 10.1097/CRD.0000000000000620
  • Verghese D, Bhat AG, Patlolla SH, et. al. "Outcomes in non-ST-segment elevation myocardial infarction complicated by in-hospital cardiac arrest based on management strategy." Indian heart journal, 75(6), (2023) 443-450. doi: 10.1016/j.ihj.2023.10.004
  • Fishkin T, Isath A, Virk HUH, et. al. "Ultrasound Guidance for Vascular Access for Coronary Angiogram: A Meta-Analysis of Randomized Controlled Trials." The American journal of cardiology, 206(), (2023) 70-72. doi: 10.1016/j.amjcard.2023.08.014
  • Desai MY, Owens A, Wolski K, et. al. "Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial." JAMA cardiology, 8(10), (2023) 968-977. doi: 10.1001/jamacardio.2023.3342
  • Ismayl M, Hussain Y, Aboeata A, et. al. "Pulmonary Artery Catheter Use and Outcomes in Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock Treated With Impella (a Nationwide Analysis from the United States)." The American journal of cardiology, 203(), (2023) 304-314. doi: 10.1016/j.amjcard.2023.06.117

View all publications.

Memberships and Affiliations

  • Past Trustee, Society for Cardiovascular Angiography and Interventions (SCAI)
  • Trustee Emeritus, Brown University
  • Past President, Brown University Medical School Board of Directors
  • President-Elect, New York Chapter of the ACC